Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.

Currently, there is no completely effective therapy available for metastatic phaeochromocytomas (PCCs) and paragangliomas. In this study, we explore new molecular targeted therapies for these tumours, using one more benign (mouse phaeochromocytoma cell (MPC)) and one more malignant (mouse tumour tis...

Descrición completa

Detalles Bibliográficos
Main Authors: Nölting, S, Garcia, E, Alusi, G, Giubellino, A, Pacak, K, Korbonits, M, Grossman, AB
Formato: Journal article
Idioma:English
Publicado: 2012

Títulos similares